CITI'S TAKE At the Citi Pan-Asia Conference, WuXi AppTec's CFO, Florence Shi, maintained 2025 guidance: revenue to reach Rmb41.5-43.0bn (10-15% yoy for continuing business) and faster bottom line growth than topline. Other key takeaways are as follows. Eyes on GLP-1 projects — Mgmt. reiterated 60%+ yoy TIDES revenue guidance for 2025. While WuXi AppTec does not disclose specific projects or clients, we believe it is involved in tirzepatide, orforglipron and retatrutide. In Apr 2025, orforglipron delivered p ...